Cargando…

SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin

Introduction Sodium glucose co-transporter 2 (SGLT2) inhibitors have become an appealing treatment for diabetes due to their favorable cardiac and renal outcomes. However, reports continue to emerge describing potentially life-threatening adverse events such as Fournier’s gangrene (FG) and diabetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stamatiades, George Alexiades, Kasbawala, Kinjal, Gugger, Aristea Sideri, Elahee, Mehreen, Majumdar, Sachin K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208740/ http://dx.doi.org/10.1210/jendso/bvaa046.984

Ejemplares similares

SUN-178 A Not So "Sweet" DKA: A Case of Euglycemic Diabetic Ketoacidosis Caused by Dapagliflozin/Liraglutide Combination
por: Sideri Gugger, Aristea, et al.
Publicado: (2019)

OR31-1 Sodium-Glucose Co-Transporter-2 Inhibitors and the Risk of Diabetic Ketoacidosis: Clinical and Biochemical Characteristics of 21 Cases
por: Stamatiades, George, et al.
Publicado: (2019)

Fournier’s Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications
por: Kasbawala, Kinjal, et al.
Publicado: (2020)

SUN-429 Pituitary Sarcoidosis: A Rare Cause of Secondary Amenorrhea
por: Elahee, Mehreen, et al.
Publicado: (2019)

SAT-088 A Novel Mutation In The Leptin Receptor Associated With Hypertriglyceridemia, Lipodystrophy And Non-alcoholic Fatty Liver
por: Viana, Gracia, et al.
Publicado: (2019)

MON-246 A Diagnostic Dilemma of Primary Versus Secondary Thyroid and Adrenal Hormone Insufficiencies: A Unique Case of Widely Metastatic Renal Cell Carcinoma After Brain Radiation
por: Gugger, Aristea Sideri, et al.
Publicado: (2020)

SUN-183 Prolonged Glycosuria after Canagliflozin Discontinuation in a Patient with Euglycemic Diabetic Ketoacidosis
por: Dai, Yufei, et al.
Publicado: (2019)

SAT-515 Anorexia and Severe Hypothyroidism Driving Persistent Ascites and Liver Injury
por: Gugger, Aristea Sideri, et al.
Publicado: (2020)

A Case of Euglycemic Diabetic Ketoacidosis Following Canagliflozin Therapy
por: Tuna, Kubra M, et al.
Publicado: (2021)

Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases
por: Stamatiades, G. A., et al.
Publicado: (2023)

MON-LB119 Euglycemic Diabetic Ketoacidosis in a Patient on Canagliflozin Presenting With Hypoglycemia
por: Inkollu, Sindhura, et al.
Publicado: (2020)

MON-700 Protective Effects of Smoking? Improved In-Hospital Mortality in Smokers Admitted for Diabetic Ketoacidosis
por: Nasserifar, Shabnam, et al.
Publicado: (2020)

SUN-169 A Case of Candidemia in a Patient with Diabetes on Canagliflozin Following Urologic Procedure
por: Raj, Rishi, et al.
Publicado: (2019)

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

SUN-LB025 Superior Mesenteric Artery Thrombosis: An Uncommon Complication of Diabetic Ketoacidosis
por: Saini, Khushpreet Kaur, et al.
Publicado: (2019)

SUN-699 Canagliflozin Induced Severe Hyponatremia- a Rare Life Threatening and Poorly Understood Complication- a Case Report
por: Dhanasekaran, Maheswaran, et al.
Publicado: (2020)

SUN-125 Role of Various Insulin Assays in the Diagnosis of Factitious Hypoglycemia
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2019)

SUN-167 Quetiapine-Induced Hypertriglyceridemia and Hyperglycemia Presenting as Simultaneous Diabetic Ketoacidosis and Acute Pancreatitis
por: Gandhi, Shriya, et al.
Publicado: (2019)

SUN-174 Severe Insulin Resistance and Diabetic Ketoacidosis after Brentuximab Vendotin and Cyclosporin Treatment
por: Lee, Hyunju, et al.
Publicado: (2019)

SUN-173 Nivolumab-Induced Fulminant Autoimmune Diabetes Presenting as Diabetic Ketoacidosis in a Patient with Melanoma
por: Parikh, Sahil, et al.
Publicado: (2019)

SUN-188 Contributing Factors Precipitation Diabetic Ketoacidosis in Patients Using Sodium-Glucose Cotransporter-2 Inhibitor
por: Attia, Jonven, et al.
Publicado: (2019)

SUN-LB036 Diabetic Ketoacidosis: A Rare Side Effect of Nivolumab Induced Insulin Dependent Diabetes Mellitus
por: Abid, Haisam, et al.
Publicado: (2019)

SUN-172 Diabetic Ketoacidosis Precipitated by Treatment with PD-1 Inhibitor: A Rare Immune Related Adverse Event
por: Qureshi, Mohammed
Publicado: (2019)

PSUN259 A Severe Case of Fournier's Gangrene Associated With Dapagliflozin
por: Syed, Shumail, et al.
Publicado: (2022)

LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
por: Patel, Janki M, et al.
Publicado: (2022)

SUN-LB029 A Case of Gestational Diabetes with Diabetic Ketoacidosis, Insulin Injection Site Reaction and Anti Insulin Antibodies in Pregnancy
por: Hakimian, Stephanie, et al.
Publicado: (2019)

SUN-615 Does Patient Location (Urban or Rural) Influence Risk Factors and Incidence Rate for 30-Day Readmission for Diabetic Ketoacidosis?
por: Varghese, Ron Thomas, et al.
Publicado: (2020)

Diabetic Ketoacidosis With Alpelisib
por: Jeun, Rebecca, et al.
Publicado: (2021)

SUN-176 Euglycemic Diabetic Ketoacidosis withSGLT2 Inhibitor Presenting as Chest Pain in a Patient with Coronary Artery Disease on a Ketogenic Diet
por: Dorcely, Brenda, et al.
Publicado: (2019)

SUN-673 Development of Euglycemic Diabetic Ketoacidosis in a Patient with Well-Controlled Type 2 Diabetes Mellitus on a Sodium-Glucose Transporter 2 Inhibitor
por: Narang, Disha K, et al.
Publicado: (2020)

Alpelisib-Induced Diabetic Ketoacidosis
por: Espinosa, Luis Borges, et al.
Publicado: (2021)

SUN-127 Diabetic Ketoacidosis Unmasking Glucose-6-Phosphate Dehydrogenase Deficiency in a 25-Year-Old Male with Diabetes Mellitus Type 2: A Case Report
por: Santiago, Aivind Gabrielle, et al.
Publicado: (2019)

MON-128 Pneumomediastinum in Diabetic Ketoacidosis
por: Poudel, Resham, et al.
Publicado: (2019)

THU282 Improved Fournier’s Gangrene Outcomes With Prior SGLT2i Or Metformin Usage
por: Venugopal, Sharini, et al.
Publicado: (2023)

Fournier Gangrene
por: Wolf, Chelsea T., et al.
Publicado: (2010)

Fournier’s gangrene
por: Cheung, Phoebe S. Y., et al.
Publicado: (2009)

Fournier gangrene
por: Parry, Nadiah
Publicado: (2015)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

SAT-670 The Perfect Storm for Diabetic Ketoacidosis
por: Abushamat, Layla A, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor
por: Manas, F N U, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hd5gip8usf5p6vt7ikdccgosa8